紀錄類型 : 書目-語言資料,印刷品: 單行本
其他作者 : Barrett, Frederick S.
出版者 : Cham, Switzerland :Springer,2022.
面頁冊數 : 1 online resource.
內容註 : Dosing psychedelics and MDMA -- Psychedelic Group Therapy -- Set and Setting: Aesthetic experiences and their contribution to psychedelic therapies -- Psychedelic-Assisted Therapy for Social Adaptability in Autistic Adults -- Foundations for Training Psychedelic Therapists -- Ayahuasca for the Treatment of Depression -- Psilocybin for the Treatment of Depression -- Ketamine for the Treatment of Depression -- The Potential of Psychedelics for End of Life and Palliative Care -- Psychedelic-Assisted Therapy for Addiction and Potential Mechanisms of Action -- Psilocybin for Tobacco Use Disorder -- Psychedelic Drugs as Anti-Inflammatory Agents -- Psilocybin for the Treatment of Obsessive-Compulsive Disorder -- Psilocybin for the Treatment of Headache and Pain Disorders -- Psilocybin for the Treatment of Neurodegenerative Disorders -- Psilocybin for Trauma-Related Disorders.
標題 : Psychopharmacology -
ISBN : 9783031121845
ISBN : 3031121848
LEADER 02180nam 2200349 a 4500
001 53810
003 NhCcYBP
005 20230924143810.1
006 m o d
007 cr un|---aucuu
008 220829s2022 sz o 000 0 eng d
020 $a9783031121845$q(electronic bk.)
020 $a3031121848$q(electronic bk.)
020 $z303112183X
020 $z9783031121838
024 7 $a10.1007/978-3-031-12184-5$2doi
035 $aebs3368342
040 $aNhCcYBP$cNhCcYBP
041 $aeng
050 4$aRM315$b.D57 2022
072 7$aPSAN$2bicssc
072 7$aMED057000$2bisacsh
072 7$aPSAN$2thema
082 04$a615.7/8$223/eng/20220901
245 00$aDisruptive psychopharmacology$h[electronic resource] /$cFrederick S. Barrett, Katrin H. Preller, editors.
260 $aCham, Switzerland :$bSpringer,$c2022.
300 $a1 online resource.
490 1 $aCurrent topics in behavioral neurosciences ;$vv. 56
505 0 $aDosing psychedelics and MDMA -- Psychedelic Group Therapy -- Set and Setting: Aesthetic experiences and their contribution to psychedelic therapies -- Psychedelic-Assisted Therapy for Social Adaptability in Autistic Adults -- Foundations for Training Psychedelic Therapists -- Ayahuasca for the Treatment of Depression -- Psilocybin for the Treatment of Depression -- Ketamine for the Treatment of Depression -- The Potential of Psychedelics for End of Life and Palliative Care -- Psychedelic-Assisted Therapy for Addiction and Potential Mechanisms of Action -- Psilocybin for Tobacco Use Disorder -- Psychedelic Drugs as Anti-Inflammatory Agents -- Psilocybin for the Treatment of Obsessive-Compulsive Disorder -- Psilocybin for the Treatment of Headache and Pain Disorders -- Psilocybin for the Treatment of Neurodegenerative Disorders -- Psilocybin for Trauma-Related Disorders.
533 $aElectronic reproduction.$bIpswich, MA$nAvailable via World Wide Web.
588 0 $aOnline resource; title from PDF title page (SpringerLink, viewed September 1, 2022).
650 0$aPsychopharmacology.$324789
650 2$aPsychopharmacology$9a$316135
700 1 $aBarrett, Frederick S.$eeditor.$3105466
700 1 $aPreller, Katrin H.$eeditor.$3105467
710 2 $aEBSCOhost$387894
776 08$iPrint version:$z303112183X$z9783031121838
830 0$aCurrent topics in behavioral neurosciences ;$vv. 59.$x1866-3389$388921
856 40$uhttps://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=3368342$zClick to View (限總院院內)